Bunnik
Bjorn Bunnik, Kudelstaart NL
Patent application number | Description | Published |
---|---|---|
20150121593 | Guzmania plant named 'BUNDEWH' - A new and distinct | 04-30-2015 |
20150201541 | Guzmania Plant Named 'G9191' - A new and distinct | 07-16-2015 |
Eduard Johannes Hendricus Bunnik, The Hague NL
Patent application number | Description | Published |
---|---|---|
20110079614 | FLUID PRODUCT DISPENSER - A dispenser includes a housing holding an assembly, including a liquid reservoir, a pump for dispensing the fluid product, and an outlet nozzle. The pump includes a liquid chamber for containing a dose of the liquid product and a pressurizing device which allows liquid product to be drawn into or expelled from the liquid chamber. The dispenser further includes a shunting chamber including a first aperture allowing flow access to the reservoir, a second aperture allowing flow access to the outlet nozzle, and a third aperture allowing flow access to the liquid chamber. The third aperture is disposed off-axis with respect to the first and second apertures. The shunting chamber further includes a mechanically actuated governing device that has two states, one defining a flow path between the first and third apertures and one defining a flow path between the third and second apertures. | 04-07-2011 |
Evelien Margaretha Bunnik, Riverside, CA US
Patent application number | Description | Published |
---|---|---|
20160122396 | THERAPEUTIC HPV16 VACCINES - Provided is designer nucleic acid constructs and polypeptides that can be used as therapeutic vaccines against HPV16. | 05-05-2016 |
Martijn Frans Ben Gerard Gebbink Bunnik, Bunnik NL
Patent application number | Description | Published |
---|---|---|
20080241165 | Cross-beta structure comprising amyloid-binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fiber formation and modulating cross-beta structure-mediated toxicity - The invention relates to the field of biochemistry, molecular biology, structural biology and medicine. More in particular, the invention relates to cross-β structures and the biological role of these cross-β structures. In one embodiment, the invention discloses a method for modulating extracellular protein degradation and/or protein clearance comprising modulating cross-β(beta) structure formation (and/or cross-β structure-mediated activity) of the protein present in the circulation. | 10-02-2008 |
Martin Bunnik, Bennebroek NL
Patent application number | Description | Published |
---|---|---|
20130254698 | PROJECT ACTIVITY MODEL - A system and method for creating a project workflow involves tracking all activities from all disciplines within a company in a database, such that when a new workflow is created, a project architect is forced to consider every activity ever performed to the workflow in relation to every discipline. Only after activities have been assigned to their appropriate disciplines, can a user filter a view of the map to hide disciplines and activities from view. This ensures that every task ever performed by various disciplines within a company is always considered whenever designing a project workflow. | 09-26-2013 |